FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 6 analysts with an average price target of $15.4. This is a potential upside of $4.53 (6.28%) from yesterday's end of day stock price of $14.49.

Amicus Therapeutics's activity chart (see below) currently has 112 price targets and 98 ratings on display. The stock rating distribution of FOLD is 12.5% HOLD and 87.5% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.5% with an average time for these price targets to be met of 282.97 days.

Highest price target for FOLD is $19, Lowest price target is $14.5, average price target is $15.4.

Most recent stock forecast was given by from JEFFERIES on 22-Jan-2026. First documented stock forecast 30-Jun-2014.

Best performing analysts who are covering FOLD - Amicus Therapeutics:

Debjit Chattopadhyay Elemer Piros Ritu Baral Anupam Rama Michael Ulz Joseph Schwartz

Currently out of the existing stock ratings of FOLD, 1 are a HOLD (12.5%), 7 are a BUY (87.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Sep-2024

$14.5

$0.01 (0.07%)

$18

7 months 23 days ago
(22-Jan-2026)

0/2 (0%)

$0.23 (1.61%)

Buy Since 24-Feb-2022

$14.5

$0.01 (0.07%)

$14

8 months 16 days ago
(29-Dec-2025)

7/11 (63.64%)

$0.25 (1.75%)

530

Buy Since 17-Dec-2025

$14.5

$0.01 (0.07%)

$17

8 months 23 days ago
(22-Dec-2025)

0/2 (0%)

$0.29 (2.04%)

Buy Since 14-Jan-2022

$14.5

$0.01 (0.07%)

$21

8 months 26 days ago
(19-Dec-2025)

0/9 (0%)

$0.32 (2.26%)

Buy Since 19-Dec-2025

$14

8 months 26 days ago
(19-Dec-2025)

1/1 (100%)

$5.52 (65.09%)

92

Show more analysts

Please expand the browser size to see the chart

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 283 days for the stock forecasts to be reached, with an average price target met ratio of 51.5%.

Which analyst most recently updated their price target on FOLD (Amicus Therapeutics)?

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

has 0 price targets and 0 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with the highest potential upside of $10.54

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Salveen Richter with the lowest potential downside of -$5.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?